With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Tech stocks and top consumer names are increasingly at risk of steep declines in a slowing economy. Click here to see 5 ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

Vertex Pharmaceuticals (VRTX) announced updated data for povetacicept in IgA nephropathy and primary membranous nephropathy from the ongoing ...

Discover the iconic hand-rolled, wood-fired bagels everyone's talking about. There are few things we believe in burning the tips of our fingers for. What is worth a momentary, yet painful, cool-down ...